Latest Kidney transplantation Stories

African Americans, individuals without private insurance less likely to receive a transplant before needing dialysis Highlights: African Americans and individuals without private health insurance are less likely to receive a kidney transplant before needing dialysis. Geographic region is not a major factor in determining whether a patient receives a kidney transplant before starting dialysis. Nearly 90,000 people in the U.S. are waiting for a kidney transplant, and many will die...

WINSTON-SALEM, N.C., Jan. 30, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced advances for its two lead programs, the Neo-Urinary Conduit(TM) and Neo-Kidney Augment(TM). "We look forward to successfully implanting the remaining three patients in the ongoing Phase 1 trial for the Neo-Urinary Conduit by the end of this quarter. Following the implantation of patient seven, we have begun to transfer the surgical procedure to...

NEW ORLEANS, Jan. 28, 2013 /PRNewswire/ -- CareChex, a division of The Delta Group specializing in rating the quality of hospital and physician care, has named the Ochsner Multi-Organ Transplant Institute number one in the country for liver transplants in its 2013 Hospital ratings. This prestigious distinction recognizes Ochsner as the top hospital in the nation out of over 100 hospitals rated for liver transplants. The CareChex Medical Quality Rating System provides a...

LAKE SUCCESS, N.Y., Jan. 18, 2013 /PRNewswire-USNewswire/ -- IPRO, one of the nation's largest healthcare quality improvement contractors, has been awarded three major federal contracts to oversee the provision of End-Stage Renal Disease (ESRD) services to Medicare beneficiaries. All three-year awards support dialysis and renal transplantation centers in maintaining high standards of care for ESRD patients. All are administered by the Centers for Medicare & Medicaid Services (CMS)...

Results come from large, randomized, placebo-controlled trial Highlight: -While safe and well-tolerated, angiotensin II blockade did not lessen tissue scarring or prevent kidney failure in kidney transplant recipients. -Angiotensin II blockade is known to slow kidney disease progression in individuals without transplants. A drug that protects the kidneys of patients with chronic kidney disease does not seem to provide the same benefit to kidney transplant recipients, according to...

KANSAS CITY, Kan., Jan. 10, 2013 /PRNewswire/ -- In the Midwest Transplant Network service area, no other hospital has transplanted more organs than The University of Kansas Hospital. Two recent patients help the hospital reach a liver transplant milestone. Brenda Higgins of Kansas City was the hospital's milestone 1,000(th) liver transplant patient, followed shortly thereafter by Deborah Ellerbusch, Ph.D., a psychologist who works in Newton, Kan. "I'm overwhelmed and overjoyed at...

SINGAPORE, Jan. 6, 2013 /PRNewswire/ -- AWAK Technologies announced today it has entered into an exclusive agreement with Baxter International, Inc. for the development of innovative wearable dialysis technology. The agreement enables AWAK to continue the development of its investigational peritoneal dialysis-based automated wearable artificial kidney. AWAK Technologies is a research-focused, medical technology company dedicated to the development and commercialization of...

HORSHOLM, Denmark, Jan. 3, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S today is announcing that the LCP-Tacro Phase III clinical trial in stable kidney transplant patients, the 3001 study, has been published online in the American Journal of Transplantation. The article reports on the randomized, controlled, multicenter Phase III trial, which demonstrated that LCP-Tacro dosed once-daily was not inferior to the current leading transplant drug, Prograf(®), dosed twice-daily....

WINSTON-SALEM, N.C., Dec. 21, 2012 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that Scott D. Flora, President & Chief Executive Officer at OmniGuide, has resigned from Tengion's Board of Directors, effective December 19, 2012. "Scott has been a valuable asset to Tengion and his expertise in the medical and surgical device arenas has been an excellent resource for the Company over the last year," reflected David Scheer, Chairman...

Missouri native in desperate need of a kidney transplant during this holiday season. Donations are welcome to help alleviate medical expenses. ST. PETERS, Mo. (PRWEB) December 15, 2012 Holidays are the times where people need others help and support the most. For Kenny Ravenscraft and his family, the support he could receive this holiday could save his life. Kenny has been diagnosed with kidney failure, and right now, two weeks before Christmas, his kidneys are only operating at 6...